Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 19th:
TrueBlue, Inc. (TBI - Free Report) : This staffing company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.
TrueBlue’s has a price-to-earnings ratio (P/E) of 14.20, compared with 31.00 for the industry. The company possesses a Value Score of A.
Prudential Financial, Inc. (PRU - Free Report) : This financial services company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Prudential Financial’s has a price-to-earnings ratio (P/E) of 9.89, compared with 12.50 for the industry. The company possesses a Value Score of A.
SORL Auto Parts, Inc. : This air brake and hydraulic brake valves producer has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings jumping 23.7% over the last 60 days.
SORL Auto Parts’ has a price-to-earnings ratio (P/E) of 4.45, compared with 9.20 for the industry. The company possesses a Value Score of A.
Select Medical Holdings Corporation (SEM - Free Report) : This healthcare company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.
Select Medical Holdings’ has a price-to-earnings ratio (P/E) of 15.23, compared with 29.00 for the industry. The company possesses a Value Score of A.
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 19th:
TrueBlue, Inc. (TBI - Free Report) : This staffing company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.
TrueBlue’s has a price-to-earnings ratio (P/E) of 14.20, compared with 31.00 for the industry. The company possesses a Value Score of A.
Prudential Financial, Inc. (PRU - Free Report) : This financial services company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Prudential Financial’s has a price-to-earnings ratio (P/E) of 9.89, compared with 12.50 for the industry. The company possesses a Value Score of A.
SORL Auto Parts, Inc. : This air brake and hydraulic brake valves producer has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings jumping 23.7% over the last 60 days.
SORL Auto Parts’ has a price-to-earnings ratio (P/E) of 4.45, compared with 9.20 for the industry. The company possesses a Value Score of A.
Select Medical Holdings Corporation (SEM - Free Report) : This healthcare company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.
Select Medical Holdings’ has a price-to-earnings ratio (P/E) of 15.23, compared with 29.00 for the industry. The company possesses a Value Score of A.
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PRU - FREE
Get the latest research report on SEM - FREE
Get the latest research report on TBI - FREE